Literature DB >> 8030405

Acute idiopathic axonal neuropathy (AIAN): a clinical and electrophysiological observation.

S K Gupta1, A B Taly, T G Suresh, S Rao, D Nagaraja.   

Abstract

Twenty patients (M:F 15:5) with electrophysiological evidence of predominant axonal lesion and fulfilling clinical criteria for Guillain Barré Syndrome were observed during a period of 6 years (1985-1990). Their mean age was 27.5 years (range 5-55). Seven patients had antecedent febrile illness. Peak motor deficit was reached at a mean period of 6.5 days (range 2-21 days). All the patients had distal muscle weakness out of proportion to proximal muscle weakness. Facial paresis (13 patients), bulbar palsy (2), respiratory failure (1), sensory deficits (7) and dysautonomia (1) were other salient features. CSF analysis revealed albumino-cytological dissociation in 12 patients. One patient died and in the remaining patients the recovery was delayed and incomplete. Presence of predominant distal muscle wasting and weakness, low amplitude CMAP or inexcitable nerves, absence of conduction block or significant temporal dispersion, normal or only slightly reduced conduction velocity and evidence of poor recovery suggest that the primary pathology in these patients may be axonal degeneration. These cases may represent a distinct entity and need to be differentiated from the more commonly observed acute idiopathic demyelinating neuropathy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8030405     DOI: 10.1111/j.1600-0404.1994.tb01665.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

1.  Outcomes of patients presenting with Guillain-Barre Syndrome at a tertiary care center in India.

Authors:  Priyank Patel; Darshil Shah; Chinmay Jani; Irmgard Behlau; Ami Parikh; Jui Shah; Ruchi Jani; Arjun Kelaiya; Jinal Pandya; Harpreet Singh; Omar Al Omari; Dhara Roy
Journal:  BMC Neurol       Date:  2022-04-22       Impact factor: 2.903

2.  Sympathetic skin response in myelopathies.

Authors:  K P Nair; A B Taly; G R Arunodaya; S Rao; T Murali
Journal:  Clin Auton Res       Date:  1998-08       Impact factor: 4.435

3.  Sympathetic skin response in Guillain-Barré syndrome.

Authors:  A B Taly; G R Arunodaya; S Rao
Journal:  Clin Auton Res       Date:  1995-09       Impact factor: 4.435

4.  Treatment guidelines for Guillain-Barré Syndrome.

Authors:  A K Meena; S V Khadilkar; J M K Murthy
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

5.  Clinical profile and predictors for outcome in children presenting with Guillain-Barré syndrome.

Authors:  Sonali Singh; Nitin Gupta; Arpita M Gupta; Anurag S Chandel; Sneha Waghela; Pallavi Saple
Journal:  J Family Med Prim Care       Date:  2020-10-30

6.  DimachkieSpectrum of Acute Neuropathy Associated with Covid-19: Clinical and electrophysiological study of 13 patients from a single center.

Authors:  Sai Deepak Yaranagula; Venkata Krishna Chaitanya Koduri
Journal:  Int J Infect Dis       Date:  2021-07-29       Impact factor: 3.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.